[Duration of antibiotic therapy for common respiratory infections in adults]
Catia Vieira Gomes1, Frank Bally1
1Service des maladies infectieuses, Institut central des hôpitaux, 1951 Sion.
Abstract:
Antibiotic therapy is not recommended for the majority of adult outpatients with a respiratory tract infection. When antibiotic therapy is mandatory, its duration should be as short as possible in order to avoid side effects and reduce costs. This literature review summarises the recommendations for new, shorter courses of antibiotics. The recommended duration of antibiotic treatment for community-acquired pneumonia, chronic obstructive pulmonary disease exacerbation and acute otitis media is now 5 days, 6 days for pharyngitis and between 5 and 7 days for sinusitis. These recommendations do not apply to severe or complicated infections, infections with resistant agents or in immunosuppressed patients.
Insights
For most adult respiratory infections, antibiotics aren't needed. Shorter antibiotic courses, like 5-7 days for specific infections, are now recommended when treatment is necessary, minimizing risks and costs.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Background:
- Respiratory tract infections (RTIs) are common in adult outpatients.
- Antibiotic overuse contributes to resistance and side effects.
- Optimizing antibiotic duration is crucial for patient outcomes and healthcare costs.
Approach:
- Literature review of current evidence and guidelines.
- Synthesis of recommendations for antibiotic treatment durations.
- Focus on common outpatient RTIs including pneumonia, COPD exacerbation, otitis media, pharyngitis, and sinusitis.
Key Points:
- Antibiotic therapy is generally not indicated for most adult outpatient RTIs.
- Shorter antibiotic courses are recommended when treatment is mandatory.
- Specific recommended durations: 5 days for community-acquired pneumonia, COPD exacerbation, and acute otitis media; 6 days for pharyngitis; 5-7 days for sinusitis.
Conclusions:
- Shorter antibiotic durations are evidence-based for common RTIs in adults.
- These shorter regimens help mitigate antibiotic resistance, side effects, and healthcare expenses.
- Exclusions apply to severe/complicated infections, resistant organisms, and immunocompromised patients.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
COPD: Management Using Bronchodilators and Corticosteroids
